in vitro: LY2795050 displays full antagonist activity and high binding affinity and selectivity for KOR with a ki value of 0.72 nM [1].
in vivo: In the brain, (11)C-LY2795050 displayed fast uptake kinetics (regional activity peak times of <20 min) and an uptake pattern consistent with the distribution of KOR in primates [1]. The LY2795050 ED50 at MOR was 119 μg/kg based on a 1-site model for 11C-carfentanil. The 1-site binding model was also deemed sufficient to describe the specific binding of 11C-LY2795050 at KOR. The ED50 at KOR estimated from the 1-site model was 15.6 μg/kg. Thus, the ED50 ratio for MOR:KOR was 7.6 [2].
Information
CAS No1346133-08-1
FormulaC23H22ClN3O2
Clinical Informationclinicalinformation
PathwayGPCR/G Protein Neuronal Signaling
TargetOpioid Receptor Opioid Receptor
Specifications
Purity / Grade>98%
SolubilityDMSO : 83.3 mg/mL (204.22 mM; Need ultrasonic)
Smilessmiles
Misc Information
Observed Molecular Weight407.89
related data
Get valuable resources and offers directly to your email.